FeLV and neoplastic disease in a Portuguese domestic cat population
PloS one · 2026
In plain language
This observational study included 1,124 cats and found a higher frequency of lymphoma, leukemia, and disorders of blood cell production called myelodysplastic processes among FeLV-positive cats. That association does not show that FeLV caused these diseases. Most cats were tested only once, and the amount of viral DNA integrated into their cells was measured mainly in sick cats, which limits the conclusions. Whether interactions between that DNA and cellular genes involved in tumor development contribute to cancer in cats with regressive infection remains unresolved.
Scientific detail
This 4.5-year cross-sectional clinical study, published in PloS one in 2026, provides direct observational data from a Portuguese population of 1,124 domestic cats. There were 127 FeLV-positive cats, including 20 coinfected with FIV. Table 4 presents groups of 107 FeLV-positive, 96 FIV-positive, 20 FeLV/FIV-positive, and 901 negative cats. The data support an association between FeLV-positive status and a higher observed frequency of lymphoma and leukemia/myelodysplastic processes in the sampled population. They do not establish causation or demonstrate an oncogenic mechanism.
The authors identify one-off testing without longitudinal retesting for most cats as the primary limitation. Diagnosis was predominantly serological, and infection course was determined in only a minority. These limitations prevent reliable determination of persistent infection status or the temporal sequence between changes in infection course and neoplastic disease. Proviral load was quantified in 66 FeLV-positive cats, mainly sick cats with FeLV-related diseases rather than as general screening. This selection could explain the observed distribution of infection courses; the characterized subset should not be considered representative of all infected cats or used to establish cancer risk by infection course.
The source raises the unresolved question of whether insertional interactions between FeLV proviral DNA and cellular proto-oncogenes contribute to neoplasia in cats with regressive infection. This is not an experimental finding of the study: the supplied material does not report tumor integration-site analysis or other direct mechanistic testing. The study also does not quantify cancer-specific risk by infection course or FeLV subgroup, and survival analysis could not be performed. In addition, the supplied document omits a substantial portion of the methods and results, limiting assessment of diagnostic criteria, statistical methods, and cancer ascertainment.
What we know
In this feline population, FeLV-positive status was associated with a higher observed frequency of lymphoma and leukemia/myelodysplastic processes. This is observational evidence, not evidence of causation. The lack of longitudinal retesting for most cats and the measurement of proviral load mainly in sick cats are documented limitations, classified in the object as level C evidence.
What we don't know
The study does not reliably establish persistent infection status or the temporal sequence between changes in infection course and neoplasia. It does not demonstrate causation or an oncogenic mechanism, and it does not determine cancer-specific risk by infection course or FeLV subgroup. The contribution of insertional interactions between proviral DNA and cellular proto-oncogenes to neoplasia in cats with regressive infection remains unresolved. No survival analysis is available, and incomplete documentation limits assessment of how cancer cases were diagnosed and analyzed.
Evidence
EvidenceLevel C — Preliminary evidenceConfidence 100/100
The authors identify one-off testing without longitudinal retesting for most cats as the study's primary limitation.
Excerpt verified in the source — verbatim, in the source's own language“The primary limitation of the present study was that the data were based on a one-off test; most of the cats were not retested over time.”
The study cannot reliably establish persistent infection status or the temporal sequence between infection-course changes and neoplastic disease. This limits longitudinal oncological interpretation.
EvidenceLevel C — Preliminary evidenceConfidence 100/100
Proviral load quantification was mainly performed in sick cats with FeLV-related diseases rather than as a general screening method.
Excerpt verified in the source — verbatim, in the source's own language“The high prevalence values for both courses, with more cats categorized in the progressive course, may be attributed to the fact that proviral load quantification was mainly performed in sick cats, with FeLV-related diseases and not as a general screening method.”
The authors identify selective testing as a possible explanation for the distribution of infection courses. The staged subset should not be assumed to represent all infected cats or to establish cancer risk by infection course.
Open questionConfidence 100/100
Whether insertional interactions between FeLV proviral DNA and cellular proto-oncogenes contribute to neoplasia in regressively infected cats remains unresolved in the source.
The introduction explicitly raises this unresolved mechanism; it is not an experimental finding of this study. The supplied material does not report tumor integration-site analysis or other direct mechanistic testing. The schema does not provide an introduction location, so the discussion label is only an approximate location.
Provenance
Source: Prevalence of feline leukemia virus infection and associated diseases in a Portuguese domestic cat population: A 4.5-year cross-sectional study.
AVA